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Persistence of fetal circulation in the newborn
L.Villet H.E.Ulmer, M.Obladen
University Childrens Hospital Heidelberg
Recently the so called syndrome of persistence of the fetal
circulation has been discovered to be an important cause of
cyanosis in newborns. Persistence of fetal circulation is
defined äs a Prolongation of the transitory pulmönary vascular
obstruction in the neonate, resulting in pulmönary hyperten-
sion and right-to-left shunting through the patent ductus ar-
teriosus and the patent foramen ovale in the absence of car-
diac malformations and respiratory distress syndrome·
PFC - syndrome : patients data
patients sex birth waight
(g)
gestational age
(weeks)
hlstory
1
2
3
4
5
6
7
Z.C.
K.H.
S.L.
R.S.
K.D.
O.A.
E.M.
f
f
f
m
m
f
m
1.200
2.730
4.350
2.500
3.800
3.060
3.240
29
37
40
39
41
38
33
idiopathic
aspiration
cytomegalie
aspiration
aspiration
EPH-gestosis
aspiration
f: female, m:
From the etiological point of view it is convenient to separate
two different types. The idiopathic type of the disease is less
common and usually not associated with any other systemic dis-
order. Persistence of the fetal circulation associated with
individual cases of severe aspiration syndrome* perinatal
asphyxia, bacterial or viral infections and hyperviscosity
syndrome characterizes a second type of the disease·
Within a one-years-period we observed PFC-syndrome in 7 out of
3^5 neonates requiring intensive care (Table 1). There was the
typical onset of Symptome within the first 12 hours of life in
all our 7 patients. Striking generaliz;ed cyanosis and apical
late systolic cardiac murmurs where an uniform pattern in all
casesf mimicking congenital cyanotic heart disease. On the other
hand predominant pulmönary diseases had to be considered because
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of significant tachypnoe and radiological eigne of parenchymal
pulmonary disease in 6 patients· Primarily polycythemia,
acidoses and hypoglycemia should be excluded or treated when
identified.
An important clue to the diagnosis of persistent fetal path-
ways is the demonstration of extrapulmonary venoarterial
shunting by the differential hyperoxia test (Table 2). Higher
values of arterial P(>2 in the ascending aorta compared to the
descending aorta evaluate right-to-left shunting through the
patent ductus arteriosus. Both values, however, usually do
not exceed 60 - 65 mm Hg·
PFC - syndrome : laboratory flndings
patient Hct
%
pH
mm Hg
pC02
mm Hg
p02
a. a.
min Hg
d.a.
1 Z.M. 37 7,23 49 55 25
2 O. 37 6,85 110 58 (23)
3 S.L. 54 7,30 30 60 40
4 R.S. 45 7,16 86 35 (24)
5 K.D. 51 7,32 141 36 (24)
6 O.A. 47 7,39 44 37 (10)
7 E.M. 40 7,19 55 49 42
a. a. : ascending aorta
d.a. : descending aorta
( ) : capillary samples
In our experience transcutaneous P02 monitoring has proven to
be äs direct arterial blood sampling. Figure l shows an origi-
nal tracing of simultaneous transcutaneous PC^-measurements
from the upper ehest and lower limb. There is only a neglec-
tible difference while breathing kO% of oxygen. Following a
ten minutes breathing of lOOJi oxygen Pct°2 demonstrates only
a small absolute rise in both curves but a significant increase
in their difference.
At this point the differential diagnosis still encludes cardiac
malformations with a ductal right-to-left shunting such äs
coarctation of the aorta bf the preductal type or interrupted
aortic arch. If these cardiac lesions are suspected and can-
not be excluded by clinical means cardiac catheterization may
be necessary.
Before considering an invasive procedure it may be tried to
decrease pulmonary vascular resistance by a test dose of
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tolazoline a potent vasodilator. Increased pulmonary perfusion
immediately results in a better arterial oxygenation of the
blood deriving from the left ventricle - upper curve - . The
admixture of this higher arterial blood to the venpus ductal
blood also increases the P02 in the descending aorta * lower
curve - however to a lesser degree.
It must bepointed out that tolazoline also decreases systemic
resistance. Severe arterial hypotension from which some pa-
tients have died has been reported in the literature. Before
the administration of tolazoline therefore special contra-
indications must be considered. Dosis regimen used, and
contraindications are shown in Fig.2.
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PFC - syndrome : tolazollne treatment
contraindications
- known or suspected cardiac malformation
- arterial p02 > 80 mm Hg or FI02 = 1,0
- congestlve heart fai lure
- systolic arterial blood pressure<60 mm Hg
dosage :
bolus injection : 1 mgAg within 30 sec
continuous Infusion : 1 - 2 mg/kg/hour Into an
arm or a scalp vein
Reviewing our cases it can be summarized:
- all infants presented äs critically ill, with central cyano-
sis and respiratory insufficiency required artificial Ven-
tilation.
- differential hypoxia test revealed significant right-to-
left shunting through the patent ductus arteriosus.
- in some cases congenital heart disease can only be excluded
by invasive diagnostic.
- tolazoline Infusion may cause dramatic improvement in the
idiopathic type and in selected cases of the secondary type,
- to avoid cerebral complications or even death long standing
hypoxemia which may be responsible for cerebral convulsions
in our cases it seems to be necessary to start treatment
äs early äs the diagnosis can be established.
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